Product Images Tirofiban Hydrochloride

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 10 images provide visual information about the product associated with Tirofiban Hydrochloride NDC 14789-102 by Nexus Pharmaceuticals Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Figure - tir00 0010 01

Figure - tir00 0010 01

Figure - tir00 0010 02

Figure - tir00 0010 02

Figure - tir00 0010 03

Figure - tir00 0010 03

Figure - tir00 0010 04

Figure - tir00 0010 04

Figure - tir00 0010 05

Figure - tir00 0010 05

Figure 1 - tir00 0010 06

Figure 1 - tir00 0010 06

Principal Display Panel – 100 mL Carton Label - tir00 0010 07

Principal Display Panel – 100 mL Carton Label - tir00 0010 07

This text appears to be a description of a medication called Tirofiban Hydrochloride Injection. It is recommended to protect the medication from light during storage and to use it with a calibrated infusion device. It is a premixed injection and comes in a single-dose container. Each 100 mL contains Tirofiban hydrochloride equivalent to 5 mg of tirofiban. The medication should be stored at a temperature between 15 to 30°C (50°F to 86°F). It is manufactured by Nexus Pharmaceutical, Inc. in the UK.*

Principal Display Panel – 100 mL Bag Label - tir00 0010 08

Principal Display Panel – 100 mL Bag Label - tir00 0010 08

This is a description for Tirofiban Hydrochloride Injection, a medication that is recommended for use with a calibrated infusion device. It comes in a 100 mL single-dose container and is only available with a prescription. The injection contains 5mg of Tirofiban hydrochloride per 100 mL, with a concentration of 50 mcg/mL. The solution is pre-mixed, iso-osmotic, sterile, and non-pyrogenic. It also contains sodium chloride, sodium citrate dihydrate, citric acid monohydrate, and water for injection. The pH of the solution can be adjusted with hydrochloric acid and/or sodium hydroxide. The usual dosage of this medication is intravenously, as directed by a physician. It is important not to add any supplementary medication to the injection. The bag should be checked for minute leaks by squeezing it firmly, and if any leaks are found, the bag should be discarded as it may affect the sterility of the solution. It is also advised not to use this medication in series connections. Additionally, the solution should only be used if it is clear. The recommended storage temperature for this medication is between 15°C to 30°C (59°F to 86°F), with excursions permitted between 15°C to 30°C (59°F to 86°F). It should not be frozen and should be protected from light during storage. The medication is manufactured in the UK for Nexus Pharmaceutical, Inc., located in Lincolnshire, IL, USA. The text does not provide information about the lot or expiration date.*

Principal Display Panel – 250 mL Carton Label - tir00 0010 09

Principal Display Panel – 250 mL Carton Label - tir00 0010 09

Principal Display Panel – 250 mL Bag Label - tir00 0010 10

Principal Display Panel – 250 mL Bag Label - tir00 0010 10

Recommended for use with a calibrated infusion device, this product is a 250 mL single-dose container of Tirofiban Hydrochloride Injection. It contains 12.5mg of Tirofiban per 250 mL, with a concentration of 50 mcg/mL. This pre-mixed solution is iso-osmotic, sterile, and non-pyrogenic. It also contains sodium chloride, sodium citrate dihydrate, citric acid monohydrate, and water for injection. The solution's pH can be adjusted with hydrochloric acid and/or sodium hydroxide. It is intended for intravenous use as directed by a physician. Care should be taken not to add supplementary medication, and any leaks should be checked for and the bag discarded if found. It should not be used in series connections and should only be used if the solution is clear. The recommended storage temperature is between 15°C to 30°C (59°F to 86°F), with excursions permitted up to 25°C (77°F). It should be protected from freezing and light during storage. Manufactured by Nexus Pharmaceuticals, LLC in Lincolnshire, IL, USA.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.